{"id":"https://openalex.org/W2011456653","doi":"https://doi.org/10.1300/j465v26n02_02","title":"A Placebo Controlled, Double-Blind Study of Mecamylamine Treatment for Cocaine Dependence in Patients Enrolled in an Opiate Replacement Program","display_name":"A Placebo Controlled, Double-Blind Study of Mecamylamine Treatment for Cocaine Dependence in Patients Enrolled in an Opiate Replacement Program","publication_year":2006,"publication_date":"2006-04-01","ids":{"openalex":"https://openalex.org/W2011456653","doi":"https://doi.org/10.1300/j465v26n02_02","mag":"2011456653","pmid":"https://pubmed.ncbi.nlm.nih.gov/16687365"},"language":"en","primary_location":{"id":"doi:10.1300/j465v26n02_02","doi":"https://doi.org/10.1300/j465v26n02_02","is_oa":false,"landing_page_url":"https://doi.org/10.1300/j465v26n02_02","pdf_url":null,"source":{"id":"https://openalex.org/S199665586","display_name":"Substance Abuse","issn_l":"0889-7077","issn":["0889-7077","1547-0164"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","norway-1","poland-70","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Substance Abuse","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111782450","display_name":"Malcolm S. Reid","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I57206974","display_name":"New York University","ror":"https://ror.org/0190ak572","country_code":"US","type":"education","lineage":["https://openalex.org/I57206974"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Malcolm S. Reid","raw_affiliation_strings":["New York University School of Medicine, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"New York University School of Medicine, USA","institution_ids":["https://openalex.org/I57206974"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113775377","display_name":"Burt Angrist","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800015068","display_name":"VA NY Harbor Healthcare System","ror":"https://ror.org/03s5r4e84","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I2800015068","https://openalex.org/I4210094901"]},{"id":"https://openalex.org/I57206974","display_name":"New York University","ror":"https://ror.org/0190ak572","country_code":"US","type":"education","lineage":["https://openalex.org/I57206974"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Burt Angrist","raw_affiliation_strings":["New York University School of Medicine, USA","V.A. New York Harbor Healthcare System, Department of Psychiatry, 423 East 23rd Street, New York, NY, 10010, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"New York University School of Medicine, USA","institution_ids":["https://openalex.org/I57206974"]},{"raw_affiliation_string":"V.A. New York Harbor Healthcare System, Department of Psychiatry, 423 East 23rd Street, New York, NY, 10010, USA","institution_ids":["https://openalex.org/I2800015068"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007191006","display_name":"Siobhan M. O'Leary","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800015068","display_name":"VA NY Harbor Healthcare System","ror":"https://ror.org/03s5r4e84","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I2800015068","https://openalex.org/I4210094901"]},{"id":"https://openalex.org/I57206974","display_name":"New York University","ror":"https://ror.org/0190ak572","country_code":"US","type":"education","lineage":["https://openalex.org/I57206974"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Siobhan O'Leary","raw_affiliation_strings":["New York University School of Medicine, USA","V.A. New York Harbor Healthcare System, Department of Psychiatry, 423 East 23rd Street, New York, NY, 10010, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"New York University School of Medicine, USA","institution_ids":["https://openalex.org/I57206974"]},{"raw_affiliation_string":"V.A. New York Harbor Healthcare System, Department of Psychiatry, 423 East 23rd Street, New York, NY, 10010, USA","institution_ids":["https://openalex.org/I2800015068"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Jennifer Stone","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800015068","display_name":"VA NY Harbor Healthcare System","ror":"https://ror.org/03s5r4e84","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I2800015068","https://openalex.org/I4210094901"]},{"id":"https://openalex.org/I57206974","display_name":"New York University","ror":"https://ror.org/0190ak572","country_code":"US","type":"education","lineage":["https://openalex.org/I57206974"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer Stone","raw_affiliation_strings":["New York University School of Medicine, USA","V.A. New York Harbor Healthcare System, Department of Psychiatry, 423 East 23rd Street, New York, NY, 10010, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"New York University School of Medicine, USA","institution_ids":["https://openalex.org/I57206974"]},{"raw_affiliation_string":"V.A. New York Harbor Healthcare System, Department of Psychiatry, 423 East 23rd Street, New York, NY, 10010, USA","institution_ids":["https://openalex.org/I2800015068"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085501338","display_name":"Marion P. Schwartz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800015068","display_name":"VA NY Harbor Healthcare System","ror":"https://ror.org/03s5r4e84","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I2800015068","https://openalex.org/I4210094901"]},{"id":"https://openalex.org/I57206974","display_name":"New York University","ror":"https://ror.org/0190ak572","country_code":"US","type":"education","lineage":["https://openalex.org/I57206974"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marion Schwartz","raw_affiliation_strings":["New York University School of Medicine, USA","V.A. New York Harbor Healthcare System, Department of Psychiatry, 423 East 23rd Street, New York, NY, 10010, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"New York University School of Medicine, USA","institution_ids":["https://openalex.org/I57206974"]},{"raw_affiliation_string":"V.A. New York Harbor Healthcare System, Department of Psychiatry, 423 East 23rd Street, New York, NY, 10010, USA","institution_ids":["https://openalex.org/I2800015068"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071920736","display_name":"John Rotrosen","orcid":"https://orcid.org/0000-0002-0283-5576","observed_orcids":["https://orcid.org/0000-0002-0283-5576"]},"institutions":[{"id":"https://openalex.org/I2800015068","display_name":"VA NY Harbor Healthcare System","ror":"https://ror.org/03s5r4e84","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I2800015068","https://openalex.org/I4210094901"]},{"id":"https://openalex.org/I57206974","display_name":"New York University","ror":"https://ror.org/0190ak572","country_code":"US","type":"education","lineage":["https://openalex.org/I57206974"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Rotrosen","raw_affiliation_strings":["New York University School of Medicine, USA","V.A. New York Harbor Healthcare System, Department of Psychiatry, 423 East 23rd Street, New York, NY, 10010, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"New York University School of Medicine, USA","institution_ids":["https://openalex.org/I57206974"]},{"raw_affiliation_string":"V.A. New York Harbor Healthcare System, Department of Psychiatry, 423 East 23rd Street, New York, NY, 10010, USA","institution_ids":["https://openalex.org/I2800015068"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112071449","display_name":"Sherryl A. Baker","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I125043107","display_name":"Nathan Kline Institute for Psychiatric Research","ror":"https://ror.org/01s434164","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I125043107"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sherryl A. Baker","raw_affiliation_strings":["Nathan Kline Institute for Psychiatric Research, 140 Old Orangeburg Road, Orangeburg, NY, 10962, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nathan Kline Institute for Psychiatric Research, 140 Old Orangeburg Road, Orangeburg, NY, 10962, USA","institution_ids":["https://openalex.org/I125043107"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103562370","display_name":"James A. Robinson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I125043107","display_name":"Nathan Kline Institute for Psychiatric Research","ror":"https://ror.org/01s434164","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I125043107"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James Robinson","raw_affiliation_strings":["Nathan Kline Institute for Psychiatric Research, 140 Old Orangeburg Road, Orangeburg, NY, 10962, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nathan Kline Institute for Psychiatric Research, 140 Old Orangeburg Road, Orangeburg, NY, 10962, USA","institution_ids":["https://openalex.org/I125043107"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030244093","display_name":"Deborah B. Leiderman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1333606569","display_name":"Center for Drug Evaluation and Research","ror":"https://ror.org/00yf3tm42","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Deborah Leiderman","raw_affiliation_strings":["Food and Drug Administration, Center for Drug Evaluation and Research, 5600 Fishers Lane, Rockville, MD, 20892-9551, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Food and Drug Administration, Center for Drug Evaluation and Research, 5600 Fishers Lane, Rockville, MD, 20892-9551, USA","institution_ids":["https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Ann Montgomery","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1327069482","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ann Montgomery","raw_affiliation_strings":["National Institute on Drug Abuse, Medications Development Division, 6001 Executive Boulevard, Room 4123, MSC 9551, Bethesda, MD, 20892-9551, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Institute on Drug Abuse, Medications Development Division, 6001 Executive Boulevard, Room 4123, MSC 9551, Bethesda, MD, 20892-9551, USA","institution_ids":["https://openalex.org/I1327069482"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102766289","display_name":"Ahmed M. Elkashef","orcid":"https://orcid.org/0000-0002-5866-8498","observed_orcids":["https://orcid.org/0000-0002-5866-8498"]},"institutions":[{"id":"https://openalex.org/I1327069482","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ahmed Elkashef","raw_affiliation_strings":["National Institute on Drug Abuse, Medications Development Division, 6001 Executive Boulevard, Room 4123, MSC 9551, Bethesda, MD, 20892-9551, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Institute on Drug Abuse, Medications Development Division, 6001 Executive Boulevard, Room 4123, MSC 9551, Bethesda, MD, 20892-9551, USA","institution_ids":["https://openalex.org/I1327069482"]}]},{"author_position":"last","author":{"id":null,"display_name":"Dorota Majewska","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1327069482","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dorota Majewska","raw_affiliation_strings":["National Institute on Drug Abuse, Medications Development Division, 6001 Executive Boulevard, Room 4123, MSC 9551, Bethesda, MD, 20892-9551, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Institute on Drug Abuse, Medications Development Division, 6001 Executive Boulevard, Room 4123, MSC 9551, Bethesda, MD, 20892-9551, USA","institution_ids":["https://openalex.org/I1327069482"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4400,"currency":"USD","value_usd":4400},"apc_paid":null,"fwci":1.4809,"has_fulltext":false,"cited_by_count":16,"citation_normalized_percentile":{"value":0.81614708,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"26","issue":"2","first_page":"5","last_page":"14"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.7993000149726868,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.7993000149726868,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.17489999532699585,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.0066999997943639755,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mecamylamine","display_name":"mecamylamine","score":0.996999979019165},{"id":"https://openalex.org/keywords/cocaine-dependence","display_name":"cocaine dependence","score":1.0},{"id":"https://openalex.org/keywords/methadone-maintenance-treatment","display_name":"methadone maintenance treatment","score":0.828000009059906},{"id":"https://openalex.org/keywords/laam","display_name":"LAAM","score":0.7570000290870667},{"id":"https://openalex.org/keywords/opioid-substitution-therapy","display_name":"opioid substitution therapy","score":0.7310000061988831},{"id":"https://openalex.org/keywords/cocaine-craving","display_name":"cocaine craving","score":0.8740000128746033},{"id":"https://openalex.org/keywords/cocaine-abstinence","display_name":"cocaine abstinence","score":0.7789999842643738},{"id":"https://openalex.org/keywords/transdermal-patch","display_name":"transdermal patch","score":0.7720000147819519},{"id":"https://openalex.org/keywords/treatment-retention","display_name":"treatment retention","score":0.4560000002384186},{"id":"https://openalex.org/keywords/cocaine-use","display_name":"cocaine use","score":0.34599998593330383}],"concepts":[{"id":"https://openalex.org/C2778140631","wikidata":"https://www.wikidata.org/wiki/Q2026938","display_name":"Opiate","level":3,"score":0.7444286942481995},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7157688736915588},{"id":"https://openalex.org/C2779796075","wikidata":"https://www.wikidata.org/wiki/Q3743188","display_name":"Cocaine dependence","level":3,"score":0.6863223910331726},{"id":"https://openalex.org/C2776880047","wikidata":"https://www.wikidata.org/wiki/Q3332124","display_name":"Mecamylamine","level":4,"score":0.6346573829650879},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5478075742721558},{"id":"https://openalex.org/C3020194580","wikidata":"https://www.wikidata.org/wiki/Q41576","display_name":"Cocaine use","level":2,"score":0.4972551167011261},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.4244697690010071},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.4233081042766571},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.4131471514701843},{"id":"https://openalex.org/C48856860","wikidata":"https://www.wikidata.org/wiki/Q12029","display_name":"Addiction","level":2,"score":0.3372640609741211},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.263577938079834},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.11853870749473572},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0977415144443512},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000279","descriptor_name":"Administration, Cutaneous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003042","descriptor_name":"Cocaine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D003042","descriptor_name":"Cocaine","qualifier_ui":"Q000652","qualifier_name":"urine","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008464","descriptor_name":"Mecamylamine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D008464","descriptor_name":"Mecamylamine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D008691","descriptor_name":"Methadone","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D008692","descriptor_name":"Methadyl Acetate","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D009294","descriptor_name":"Narcotics","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D009519","descriptor_name":"New York City","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014505","descriptor_name":"Urban Population","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018733","descriptor_name":"Nicotinic Antagonists","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D018733","descriptor_name":"Nicotinic Antagonists","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D019970","descriptor_name":"Cocaine-Related Disorders","qualifier_ui":"Q000534","qualifier_name":"rehabilitation","is_major_topic":true},{"descriptor_ui":"D019970","descriptor_name":"Cocaine-Related Disorders","qualifier_ui":"Q000652","qualifier_name":"urine","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1300/j465v26n02_02","doi":"https://doi.org/10.1300/j465v26n02_02","is_oa":false,"landing_page_url":"https://doi.org/10.1300/j465v26n02_02","pdf_url":null,"source":{"id":"https://openalex.org/S199665586","display_name":"Substance Abuse","issn_l":"0889-7077","issn":["0889-7077","1547-0164"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","norway-1","poland-70","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Substance Abuse","raw_type":"journal-article"},{"id":"pmid:16687365","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16687365","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Substance abuse","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[{"id":"https://openalex.org/G2966221394","display_name":null,"funder_award_id":"Y01-DA50038","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"}],"funders":[{"id":"https://openalex.org/F4320337347","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":17,"referenced_works":["https://openalex.org/W172596970","https://openalex.org/W1965616809","https://openalex.org/W1969169809","https://openalex.org/W1970168883","https://openalex.org/W1977171463","https://openalex.org/W1983190599","https://openalex.org/W1988791157","https://openalex.org/W2014309205","https://openalex.org/W2033414461","https://openalex.org/W2034947167","https://openalex.org/W2045860898","https://openalex.org/W2049796721","https://openalex.org/W2060456774","https://openalex.org/W2065537363","https://openalex.org/W2096690433","https://openalex.org/W2128020995","https://openalex.org/W2156998766"],"related_works":["https://openalex.org/W2045573797","https://openalex.org/W2288337919","https://openalex.org/W2128020995","https://openalex.org/W2008441751","https://openalex.org/W2065384856","https://openalex.org/W2072242488","https://openalex.org/W2060456774","https://openalex.org/W2014309205","https://openalex.org/W2096595409","https://openalex.org/W1987272850"],"abstract_inverted_index":{"A":[0],"placebo":[1,29,45,144],"controlled,":[2],"double-blind":[3],"trial":[4],"of":[5,8,62,136,154,159],"mecamylamine":[6,41,155],"treatment":[7,51,85,104,158],"cocaine":[9,24,63,65,89,97,108,110,128,137,160],"dependence":[10,138,161],"was":[11,75],"performed":[12],"in":[13,119,127,142,162],"methadone":[14,163],"or":[15,44,164],"LAAM":[16,165],"maintained":[17,166],"subjects":[18,34],"who":[19],"met":[20],"DSM-IV":[21],"criteria":[22],"for":[23,48,88,156],"dependence.":[25],"After":[26],"an":[27],"eight-week":[28],"run-in":[30],"screening":[31],"period,":[32],"35":[33],"were":[35],"randomly":[36],"assigned":[37],"to":[38],"receive":[39],"either":[40],"(6":[42],"mg/day)":[43],"transdermal":[46],"patches":[47],"a":[49,123],"16-week":[50],"period.":[52],"Outcome":[53],"measures":[54],"included":[55],"quantitative":[56],"urine":[57,93],"benzoylecognine":[58],"(BE)":[59],"levels,":[60],"self-report":[61],"use,":[64,90,109],"craving,":[66,111],"global":[67,113],"impression":[68,114],"scores,":[69],"mood,":[70],"retention,":[71],"and":[72,78,96,112,133],"safety.":[73],"Mecamylamine":[74],"well":[76],"tolerated,":[77],"study":[79,148],"retention":[80],"did":[81,100],"not":[82,101,150],"differ":[83,102],"by":[84,103],"group.":[86,105,145],"Evidence":[87],"based":[91],"on":[92],"BE":[94],"levels":[95],"abstinence":[98],"rates,":[99],"Self":[106],"reported":[107],"scores":[115],"showed":[116],"moderate":[117],"improvement":[118],"both":[120],"groups,":[121],"with":[122],"significantly":[124],"greater":[125],"reduction":[126],"craving":[129],"(p":[130,139],"<":[131,140],"0.05)":[132,141],"self-rated":[134],"severity":[135],"the":[143,152,157],"This":[146],"pilot":[147],"does":[149],"support":[151],"effectiveness":[153],"patients.":[167]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}